Abstract
COVID-19 has claimed more than 2.7 × 106 lives and resulted in over 124 × 106 infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation, characterize their performance, and highlight science advances that these capabilities have enabled.
Original language | English |
---|---|
Title of host publication | Proceedings of the Platform for Advanced Scientific Computing Conference, PASC 2021 |
Publisher | Association for Computing Machinery, Inc |
ISBN (Electronic) | 9781450385633 |
DOIs | |
State | Published - Jul 5 2021 |
Event | 2021 Platform for Advanced Scientific Computing Conference, PASC 2021 - Virtual, Online, Switzerland Duration: Jul 5 2021 → Jul 9 2021 |
Publication series
Name | Proceedings of the Platform for Advanced Scientific Computing Conference, PASC 2021 |
---|
Conference
Conference | 2021 Platform for Advanced Scientific Computing Conference, PASC 2021 |
---|---|
Country/Territory | Switzerland |
City | Virtual, Online |
Period | 07/5/21 → 07/9/21 |
Funding
Research was supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory; as part of the CANDLE project by the ECP (17-SC-20-SC); UK MRC Medical Bioinformatics project (grant no. MR/L016311/1), UKCOMES (grant no. EP/L00030X/1); EU H2020 CompBioMed2 Centre of Excellence (grant no. 823712), and support from the UCL Provost. Access to SuperMUC-NG (LRZ) was made possible by a special COVID-19 allocation award from the Gauss Centre for Supercomputing in Germany. Anda Trifan acknowledges support from the United States Department of Energy through the Computational Sciences Graduate Fellowship (DOE CSGF) under grant number: DE-SC0019323. We acknowledge support and allocation from TACC and OLCF. The effectiveness and impact of the infrastructure are evidenced by its use to sustain a campaign on multiple heterogeneous platforms over months to generate valuable scientific insight (§5). This work is a harbinger of the evolving role of supercomputers, viz., increasingly important generators of data for powerful ML models (e.g., WF1). In general, supercomputers will have to support campaigns with diverse components, viz., physics-based simulations, data generation and analysis, and ML/AI tasks. These individual workflows have different computational characteristics and performance challenges. They encompass high-throughput function calls, ensembles of MPI-based simulations, and AI-driven HPC simulations. There are no “turnkey solutions” to support such campaigns across multiple heterogeneous platforms, with the necessary performance and scale to ensure the required throughput. This has necessitated the design, development, and iterative improvement of infrastructure to advance therapeutics for COVID-19 and beyond. Acknowledgements: Research was supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory; as part of the CANDLE project by the ECP (17-SC-20-SC); UK MRC Medical Bioinformatics project (grant no. MR/L016311/1), UKCOMES (grant no. EP/L00030X/1); EU H2020 CompBioMed2 Centre of Excellence (grant no. 823712), and support from the UCL Provost. Access to SuperMUC-NG (LRZ) was made possible by a special COVID-19 allocation award from the Gauss Centre for Supercomputing in Germany. Anda Trifan acknowledges support from the United States Department of Energy through the Computational Sciences Graduate Fellowship (DOE CSGF) under grant number: DE-SC0019323. We acknowledge support and allocation from TACC and OLCF.
Funders | Funder number |
---|---|
Gauss Centre for Supercomputing | |
H2020 CompBioMed2 Centre of Excellence | 823712 |
National Virtual Biotechnology Laboratory | 17-SC-20-SC |
OLCF | |
TACC | |
UCL Provost | |
UKCOMES | EP/L00030X/1 |
U.S. Department of Energy | DE-SC0019323 |
Office of Science | |
Medical Research Council | MR/L016311/1 |
Keywords
- COVID-19
- Docking molecular dynamics
- Free energy estimation
- High-performance computing
- Machine learning
- Workflows